TABIIY DORI VOSITALARININGSINTETIK DORI VOSITALARIDAN FARQI

Article Sidebar

PDF (Русский)
Issue: Vol. 3 No. 18 : Young scientists
Section: Maqolalar
Published:

Main Article Content

Qo’qon universiteti Andijon filliali Tibbiyot fakulteti farmatsiya yo’nalishi talabasi.
info@in-academy.uz

Abstract:

Ushbu maqolada tabiiy va sintetik dorilarning o‘zaro farqlari, afzalliklari hamda kamchiliklari ilmiy jihatdan tahlil qilinadi. Shuningdek ushbu ikki turdagi dorilarning inson organizmiga ta’siri, nojo‘ya ta’sirlari, dozalash aniqligi va ilmiy asoslanganligi jihatidan solishtirma tahlil keltirilgan. Misollar, statistik ma’lumotlar va ilmiy manbalar asosida mavzuning dolzarbligi yoritilgan.

Article Details

How to Cite:

Numanova , D. (2025). TABIIY DORI VOSITALARININGSINTETIK DORI VOSITALARIDAN FARQI. Young Scientists, 3(18), 43–46. Retrieved from https://in-academy.uz/index.php/yo/article/view/53083

References:

Wang X. et al. Multi-target mechanisms of QiShenYiQi for myocardial infarction based on network pharmacology. https://pubmed.ncbi.nlm.nih.gov/24817581/

Huang J. et al. Potential multi-target treatment of Alzheimer’s disease usingSelaginella.https://www.frontiersin.org/articles/10.3389/fphar.2017.00539/full

Kongkaew, C., Phan, D. T. A., Janusorn, P., & Mongkhon, P. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance, 10(1), e63808.https://pubmed.ncbi.nlm.nih.gov/39208414/

Gafner S. (2020). Challenges in ensuring quality of herbal dietary supplements.https://www.herbalgram.org/resources/herbalgram/issues/127/table-of-contents/hg127-herbquality/

World Health Organization (WHO).WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants.https://apps.who.int/iris/handle/10665/42783

Kongkaew C. et al. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases. https://pubmed.ncbi.nlm.nih.gov/39208414/

Gafner, S. (2020).Challenges in ensuring quality of herbal dietary supplements – HerbalGram. https://www.herbalgram.org/resources/herbalgram/issues/127/table-of-contents/hg127-herbquality

FDA (U.S. Food and Drug Administration).Drug Development and Approval Process. https://www.fda.gov/drugs/development-approval-process-drugs

WHO Model List of Essential Medicines (2023). https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.01